查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631502

持续皮下胰岛素输注市场规模、份额、趋势分析报告：按产品、患者类型、最终用途、地区和细分市场进行预测，2025-2030 年

Continuous Subcutaneous Insulin Infusion Market Size, Share & Trends Analysis Report By Product (Patch Pumps, Tethered Pumps), By Patient Type (Diabetes Type 1, Diabetes Type 2), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

持续皮下胰岛素输注市场的成长与趋势

根据 Grand View Research, Inc. 的一份新报告，全球持续皮下胰岛素输注市场预计到 2030 年将达到 11.4 亿美元。预计 2025 年至 2030 年间市场复合年增长率为 9.0%。市场驱动因素包括糖尿病人口的增加和糖尿病治疗领域的技术进步。

根据国际糖尿病联盟（IDF）的数据，糖尿病患者总数预计将增加51.0%，从2019年的4.63亿增加到2045年的7亿。医疗成本的上涨和预防医学意识的增强预计将推动市场成长。据IDF称，全球糖尿病医疗总支出估计为7,600亿美元，预计到2045年将成长到8,450亿美元。此外，政府加强传播糖尿病认知，也促进了先进糖尿病管理设备的采用。澳洲政府推出了2016-2020年澳洲国家糖尿病战略。该战略旨在追踪该国对疫情的反应，并告知各级政府如何在现有的有限医疗保健条件下更好地进行针对性治疗。

不断增加的产品发布和人工智慧的出现正在推动市场成长。许多新兴企业正在改变CSII疗法。这些公司正致力于借助人工智慧技术来减轻糖尿病负担。这些公司正在利用技术进步来改进市场解决方案，例如整合胰岛素帮浦、非侵入性胰岛素输送系统和闭合迴路人工胰臟。

持续皮下胰岛素输注市场报告重点

  • 由于对便利、可客製化的胰岛素输送解决方案的需求不断增加，以满足对胰岛素需求较高的人群（例如 2 型糖尿病患者），预计贴片帮浦市场在预测期内将以 10.2% 的最快复合年增长率成长。
  • 2024 年，1 型糖尿病占据最大的市场占有率，为 82.1%。这是因为全球 1 型糖尿病的盛行率不断上升，需要高效、持续的胰岛素输送解决方案来更好地控制血糖。
  • 预计第 2 型糖尿病领域将以最快的速度成长，预测期内复合年增长率为 10.0%。
  • 2024 年北美持续皮下胰岛素输注市场占有最大份额，为 39.2%。这是由于配备了进餐检测技术和自动胰岛素校正功能的先进胰岛素帮浦核准，从而增强了血糖控制并使患者的糖尿病管理更加便捷。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 持续性皮下胰岛素输注市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析 – 波特五力分析
    • PESTLE分析

4. 持续皮下胰岛素输注市场：产品业务分析

  • 2024 年及 2030 年产品市场占有率
  • 产品细分仪表板
  • 2018 年至 2030 年按产品分類的市场规模、预测与趋势分析
  • 贴片帮浦
  • 繫绳帮浦

5. 持续皮下胰岛素输注市场-病患类型业务分析

  • 2024 年及 2030 年病患类型市场占有率
  • 患者类型细分仪表板
  • 2018 年至 2030 年按患者类型分類的市场规模、预测和趋势分析
  • 1 型糖尿病
  • 2 型糖尿病

6. 持续皮下胰岛素输注市场-最终用途业务分析

  • 2024 年及 2030 年终端用途市场占有率
  • 最终用途细分仪表板
  • 2018 年至 2030 年按最终用途分類的市场规模、预测和趋势分析
  • 医院和诊所
  • 居家医疗
  • 实验室

7. 持续皮下胰岛素输注市场：按产品、患者类型、最终用途和地区进行的估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030 年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Medtronic
    • F. Hoffmann-La Roche Ltd
    • ZEALAND PHARMA
    • CeQur Simplicity
    • Insulet Corporation
    • YPSOMED
    • B. Braun SE
    • BD（Becton, Dickinson and Company）
Product Code: GVR-4-68038-482-6

Continuous Subcutaneous Insulin Infusion Market Growth & Trends:

The global continuous subcutaneous insulin infusion market size is anticipated to reach USD 1.14 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.0% from 2025 to 2030. The key drivers of the market include increasing number of diabetes population coupled with technological advancement in the field of diabetes care.

According to International Diabetes Federation (IDF), the total number of diabetic population is expected to grow by 51.0% from 463.0 million in 2019 to 700.0 million in 2045. Rising health expenditure and growing awareness about preventive care is expected to boost market growth. According to the IDF, the estimated total global health expenditure to diabetes was USD 760.0 billion and is projected to grow to USD 845.0 billion by 2045. Furthermore, rising government initiatives to spread the awareness about diabetes is propelling the adoption of advanced diabetes management devices. Australian government launched Australian National Diabetes Strategy 2016 to 2020. The strategy aims to trace country's national response to this epidemic and inform how existing limited healthcare can be better targeted across all level of government.

Increasing number of product launches and advent of artificial intelligence in the market is boosting the growth. Many startups are transforming CSII therapy. These companies are taking initiatives to lessen the burden of diabetes with help of AI technology. They are leveraging technological advancement to improve market solutions like integrated insulin pumps, non-invasive insulin delivery systems, and closed-loop artificial pancreases.

Continuous Subcutaneous Insulin Infusion Market Report Highlights:

  • The patch pump segment is expected to grow at the fastest CAGR of 10.2% over the forecast period, owing to the increasing demand for convenient, customizable insulin delivery solutions that cater to people with higher insulin requirements, such as those with Type 2 diabetes.
  • The diabetes type 1 segment held the largest market share of 82.1% in 2024, which can be attributed to the growing global prevalence of diabetes type 1, necessitating efficient and continuous insulin delivery solutions for better blood sugar management.
  • The diabetes type 2 segment is expected to grow at the fastest CAGR of 10.0% over the forecast period.
  • North America continuous subcutaneous insulin infusion market held the largest share of 39.2% in 2024, which can be attributed to the approval of advanced insulin pumps that feature meal detection technology and automatic insulin corrections, enhancing blood sugar control and making diabetes management more convenient for patients.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Patient Type
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Continuous Subcutaneous Insulin Infusion Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Continuous Subcutaneous Insulin Infusion Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Patch Pumps
    • 4.4.1. Patch pumps market, 2018 - 2030 (USD Million)
    • 4.4.2. Basal
      • 4.4.2.1. Basal market, 2018 - 2030 (USD Million)
    • 4.4.3. Bolus
      • 4.4.3.1. Bolus market, 2018 - 2030 (USD Million)
    • 4.4.4. Basal and Bolus
      • 4.4.4.1. Basal and bolus market, 2018 - 2030 (USD Million)
  • 4.5. Tethered Pumps
    • 4.5.1. Tethered pumps market, 2018 - 2030 (USD Million)
    • 4.5.2. Insulin Reservoir or Cartridges
      • 4.5.2.1. Insulin reservoir or cartridges market, 2018 - 2030 (USD Million)
    • 4.5.3. Insulin Set Insertion Devices
      • 4.5.3.1. Insulin set insertion devices market, 2018 - 2030 (USD Million)
    • 4.5.4. Battery
      • 4.5.4.1. Battery market, 2018 - 2030 (USD Million)

Chapter 5. Continuous Subcutaneous Insulin Infusion Market: Patient Type Business Analysis

  • 5.1. Patient Type Market Share, 2024 & 2030
  • 5.2. Patient Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Patient Type, 2018 to 2030 (USD Million)
  • 5.4. Diabetes Type 1
    • 5.4.1. Diabetes type 1 market, 2018 - 2030 (USD Million)
  • 5.5. Diabetes Type 2
    • 5.5.1. Diabetes type 2 market, 2018 - 2030 (USD Million)

Chapter 6. Continuous Subcutaneous Insulin Infusion Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals & Clinics
    • 6.4.1. Hospitals & clinics market, 2018 - 2030 (USD Million)
  • 6.5. Homecare
    • 6.5.1. Homecare market, 2018 - 2030 (USD Million)
  • 6.6. Laboratories
    • 6.6.1. Laboratories market, 2018 - 2030 (USD Million)

Chapter 7. Continuous Subcutaneous Insulin Infusion Market: Regional Estimates & Trend Analysis by Product, Patient Type, and End Use

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamic
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive insights
      • 7.4.2.4. U.S. continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamic
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive insights
      • 7.4.3.4. Canada continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamic
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive insights
      • 7.4.4.4. Mexico continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamic
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive insights
      • 7.5.2.4. UK continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamic
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive insights
      • 7.5.3.4. Germany continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamic
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive insights
      • 7.5.4.4. France continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamic
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive insights
      • 7.5.5.4. Italy continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamic
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive insights
      • 7.5.6.4. Spain continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamic
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive insights
      • 7.5.7.4. Denmark continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamic
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive insights
      • 7.5.8.4. Sweden continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamic
      • 7.5.9.2. Regulatory framework
      • 7.5.9.3. Competitive insights
      • 7.5.9.4. Norway continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamic
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive insights
      • 7.6.2.4. Japan continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamic
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive insights
      • 7.6.3.4. China continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamic
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive insights
      • 7.6.4.4. India continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamic
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive insights
      • 7.6.5.4. Australia continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamic
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive insights
      • 7.6.6.4. South Korea continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamic
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive insights
      • 7.6.7.4. Thailand continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamic
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive insights
      • 7.7.2.4. Brazil continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamic
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive insights
      • 7.7.3.4. Argentina continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamic
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive insights
      • 7.8.2.4. South Africa continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamic
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive insights
      • 7.8.3.4. Saudi Arabia continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamic
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive insights
      • 7.8.4.4. UAE continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamic
      • 7.8.5.2. Regulatory framework
      • 7.8.5.3. Competitive insights
      • 7.8.5.4. Kuwait continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Medtronic
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Product benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. F. Hoffmann-La Roche Ltd
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Product benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. ZEALAND PHARMA
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Product benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. CeQur Simplicity
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Product benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. Insulet Corporation
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Product benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. YPSOMED
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Product benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. B. Braun SE
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. BD (Becton, Dickinson and Company)
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product benchmarking
      • 8.5.8.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global continuous subcutaneous insulin infusion market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 5. Global continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 6. Global continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 7. North America continuous subcutaneous insulin infusion market, by country, 2018 - 2030 (USD Million)
  • Table 8. North America continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 9. North America continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 10. North America continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 11. U.S. continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 12. U.S. continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 13. U.S. continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 14. Canada continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 15. Canada continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 16. Canada continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 17. Mexico continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 18. Mexico continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 19. Mexico continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 20. Europe continuous subcutaneous insulin infusion market, by country, 2018 - 2030 (USD Million)
  • Table 21. Europe continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 22. Europe continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 23. Europe continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 24. UK continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 25. UK continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 26. UK continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 27. Germany continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 28. Germany continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 29. Germany continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 30. France continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 31. France continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 32. France continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 33. Italy continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 34. Italy continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 35. Italy continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 36. Spain continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 37. Spain continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 38. Spain continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 39. Denmark continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 40. Denmark continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 41. Denmark continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 42. Sweden continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 43. Sweden continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 44. Sweden continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 45. Norway continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 46. Norway continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 47. Norway continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific continuous subcutaneous insulin infusion market, by country, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 51. Asia Pacific continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 52. Japan continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 53. Japan continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 54. Japan continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 55. China continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 56. China continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 57. China continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 58. India continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 59. India continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 60. India continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 61. Australia continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 62. Australia continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 63. Australia continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 64. South Korea continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 65. South Korea continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 66. South Korea continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 67. Thailand continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 68. Thailand continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 69. Thailand continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 70. Latin America continuous subcutaneous insulin infusion market, by country, 2018 - 2030 (USD Million)
  • Table 71. Latin America continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 72. Latin America continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 73. Latin America continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 74. Brazil continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 75. Brazil continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 76. Brazil continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 77. Argentina continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 78. Argentina continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 79. Argentina continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa continuous subcutaneous insulin infusion market, by country, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 83. Middle East & Africa continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 84. South Africa continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 85. South Africa continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 86. South Africa continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 90. UAE continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 91. UAE continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 92. UAE continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
  • Table 93. Kuwait continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
  • Table 94. Kuwait continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
  • Table 95. Kuwait continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Continuous subcutaneous insulin infusion market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product and patient type outlook (USD Million)
  • Fig. 10 End use outlook
  • Fig. 11 Competitive landscape
  • Fig. 12 Continuous subcutaneous insulin infusion market dynamics
  • Fig. 13 Continuous subcutaneous insulin infusion market: Porter's five forces analysis
  • Fig. 14 Continuous subcutaneous insulin infusion market: PESTLE analysis
  • Fig. 15 Continuous subcutaneous insulin infusion market: Product segment dashboard
  • Fig. 16 Continuous subcutaneous insulin infusion market: Product market share analysis, 2024 & 2030
  • Fig. 17 Patch pumps market, 2018 - 2030 (USD Million)
  • Fig. 18 Tethered pumps market, 2018 - 2030 (USD Million)
  • Fig. 19 Continuous subcutaneous insulin infusion market: Patient type segment dashboard
  • Fig. 20 Continuous subcutaneous insulin infusion market: Patient type market share analysis, 2024 & 2030
  • Fig. 21 Diabetes type 1 market, 2018 - 2030 (USD Million)
  • Fig. 22 Diabetes type 2 market, 2018 - 2030 (USD Million)
  • Fig. 23 Continuous subcutaneous insulin infusion market: End use segment dashboard
  • Fig. 24 Continuous subcutaneous insulin infusion market: End use market share analysis, 2024 & 2030
  • Fig. 25 Hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 26 Homecare market, 2018 - 2030 (USD Million)
  • Fig. 27 Laboratories market, 2018 - 2030 (USD Million)
  • Fig. 28 Continuous subcutaneous insulin infusion market revenue, by region
  • Fig. 29 Regional marketplace: Key takeaways
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 North America continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. country dynamics
  • Fig. 33 U.S. continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada country dynamics
  • Fig. 35 Canada continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico country dynamics
  • Fig. 37 Mexico continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 39 UK country dynamics
  • Fig. 40 UK continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany country dynamics
  • Fig. 42 Germany continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 43 France country dynamics
  • Fig. 44 France continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 45 Italy country dynamics
  • Fig. 46 Italy continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 47 Spain country dynamics
  • Fig. 48 Spain continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark country dynamics
  • Fig. 50 Denmark continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden country dynamics
  • Fig. 52 Sweden continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 53 Norway country dynamics
  • Fig. 54 Norway continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 56 Japan country dynamics
  • Fig. 57 Japan continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 58 China country dynamics
  • Fig. 59 China continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 60 India country dynamics
  • Fig. 61 India continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 62 Australia country dynamics
  • Fig. 63 Australia continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea country dynamics
  • Fig. 65 South Korea continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand country dynamics
  • Fig. 67 Thailand continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 68 Latin America continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil country dynamics
  • Fig. 70 Brazil continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 71 Argentina country dynamics
  • Fig. 72 Argentina continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 73 MEA continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa country dynamics
  • Fig. 75 South Africa continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 76 Saudi Arabia country dynamics
  • Fig. 77 Saudi Arabia continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 78 UAE country dynamics
  • Fig. 79 UAE continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 80 Kuwait Key country dynamics
  • Fig. 81 Kuwait continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
  • Fig. 82 Company categorization
  • Fig. 83 Company market position analysis
  • Fig. 84 Strategic framework